Pyxis Oncology Stock Quote PYXS - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.61

Bid

1.60

Ask

1.69

Volume

1,778,853

1.51 Day's Range 1.695

1.49 52 Week Range 6.85

Market Cap

95.74M

Previous Close

1.54

Open

1.54

Last Trade

160

1.61

(formt)

Last Trade Time

Financial Volume

$ 2,836,238

VWAP

1.5944

Average Volume (3m)

1,232,758

Shares Outstanding

59,465,729

Dividend Yield

PE Ratio

-1.35

Earnings Per Share (EPS)

-1.24

Revenue

Net Profit

-73.79M

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the ... Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

pyxisoncology.com

Headquarters

Wilmington, Delaware, USA

Founded

Pyxis Oncology Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PYXS. The last closing price for Pyxis Oncology was $1.54. Over the last year, Pyxis Oncology shares have traded in a share price range of $ 1.49 to $ 6.85.

Pyxis Oncology currently has 59,465,729 shares outstanding. The market capitalization of Pyxis Oncology is $91.58 million. Pyxis Oncology has a price to earnings ratio (PE ratio) of -1.35.

Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201

BOSTON, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.09	5.92105263158	1.52	1.71	1.49	887580	1.60042669	CS
4	-0.49	-23.3333333333	2.1	2.12	1.49	1607549	1.78880305	CS
12	-2.15	-57.1808510638	3.76	5.3899	1.49	1232758	2.62803146	CS
26	-1.8	-52.7859237537	3.41	5.3899	1.49	893795	2.9156537	CS
52	-0.17	-9.55056179775	1.78	6.85	1.49	767177	3.5646958	CS
156	-6.81	-80.8788598575	8.42	11.5	1.1	656570	3.72758181	CS
260	-17.39	-91.5263157895	19	19	1.1	634297	3.95242371	CS

PYXS - Frequently Asked Questions (FAQ)

What is the current Pyxis Oncology share price?

The current share price of Pyxis Oncology is $ 1.61

How many Pyxis Oncology shares are in issue?

Pyxis Oncology has 59,465,729 shares in issue

What is the market cap of Pyxis Oncology?

The market capitalisation of Pyxis Oncology is USD 91.58M

What is the 1 year trading range for Pyxis Oncology share price?

Pyxis Oncology has traded in the range of $ 1.49 to $ 6.85 during the past year

What is the PE ratio of Pyxis Oncology?

The price to earnings ratio of Pyxis Oncology is -1.35

What is the reporting currency for Pyxis Oncology?

Pyxis Oncology reports financial results in USD

What is the latest annual profit for Pyxis Oncology?

The latest annual profit of Pyxis Oncology is USD -73.79M

What is the registered address of Pyxis Oncology?

The registered address for Pyxis Oncology is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Pyxis Oncology website address?

The website address for Pyxis Oncology is pyxisoncology.com

Which industry sector does Pyxis Oncology operate in?

Pyxis Oncology operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MYSZMy Size Inc	$ 4.2001 (211.12%)	121.03M
NVNINVNI Group Ltd	$ 8.26 (209.36%)	78.06M
TPICTPI Composites Inc	$ 2.45 (100.82%)	34M
ICGIntchains Group Ltd	$ 8.77 (88.60%)	527.94k
HSDTHelius Medical Technologies Inc	$ 0.884851 (84.34%)	121.95M
CYNCYNGN Inc	$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	$ 0.24 (65.06%)	354.33M
NVDANVIDIA Corporation	$ 134.70 (3.08%)	310.19M
APTOAptose Biosciences Inc	$ 0.28 (64.51%)	306.25M
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.606999 (6.49%)	293.22M
PLTRPalantir Technologies Inc	$ 80.55 (8.54%)	281.23M